$83 -0.1 -0.1%
Last Trade - 31/07/18
| Market Cap | £n/a |
| Enterprise Value | £n/a |
| Revenue | £180.0m |
| Position in Universe | th / 7397 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 180.9 | 162 | 202.6 | 218.9 | 227.2 | 244.7 | 279.2 | 299.7 | +6.2% | ||
| +53.9 | -19.9 | +27.0 | +48.7 | +5.9 | -7.7 | +14.6 | +12.0 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2022
|
31st Dec 2023
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.
| Last Annual | March 31st, 2018 |
| Last Interim | March 31st, 2018 |
| Incorporated | January 12, 1989 |
| Public Since | January 23, 1992 |
| No. of Shareholders: | 77 |
| No. of Employees: | 656 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 22,698,000 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 3240 Whipple Rd, UNION CITY, 94587-1217, United States |
| Web | http://www.abaxis.com/ |
| Phone | +1 510 6756500 |
| Contact | () |
| Auditors | BPM LLP |
As of 31/07/18, shares in Abaxis Inc are trading at $83, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in Abaxis Inc are currently trading at $83 and the price has moved by 76.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Abaxis Inc price has moved by 50.12% over the past year.
Of the analysts with advisory recommendations for Abaxis Inc, there are there are currently 1 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Abaxis Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Abaxis Inc is scheduled to issue upcoming financial results on the following dates:
The Abaxis Inc dividend yield is % based on the trailing twelve month period.
Last year, Abaxis Inc paid a total dividend of 0.6, and it currently has a trailing dividend yield of %. Looking ahead, Abaxis Inc has not announced an ex-dividend date yet.
Abaxis Inc has yet to annouce their ex-dividend date. The historic dividend yield on Abaxis Inc shares is currently %.
To buy shares in Abaxis Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Abaxis Inc are currently trading at $83, giving the company a market capitalisation of £n/a.
Here are the trading details for Abaxis Inc:
We were not able to load our ranking data for Abaxis Inc
We were not able to load any forecast data for Abaxis Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abaxis Inc. Over the past six months, the relative strength of its shares against the market has been 11.42%. At the current price of $83, shares in Abaxis Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Abaxis Inc.
Abaxis Inc's management team is headed by:
Here are the top five shareholders of Abaxis Inc based on the size of their shareholding:
